Table 3 Results of logistic regression analyses explaining ANT-adherence in the total sample, clozapine and non-clozapine groups

OR

OR

OR

OR

Age

1.01

1.02

1.02

1.01

Sex

2.17

1.99

1.63

2.14

Chlorpromazine equivalent

1.00

1.00

1.00

1.00*

ANT-attitude

1.04**

1.04**

1.03*

1.03*

ANT-insight

1.00

1.00

1.00

1.01

ANT-adverse effects

1.02

1.02

1.01

1.01

BPRS_total

0.97

BPRS_positive symptoms

0.95

HONOS_total

0.96

HONOS_behaviour

1.24

HONOS_impairment

0.94

HONOS_symptoms

0.75

HONOS_social

1.20

ADL

0.73

0.73

0.77

0.74

IADL

1.19

1.22

1.2

1.25

social functioning

0.82

0.84

0.80

0.80

Nagelkerke R square

0.22

0.23

0.21

0.25

p for the model

< 0.001

< 0.001

< 0.001

< 0.001

 Age

1.03

1.04

1.04

1.04

 Sex

1.67

1.46

1.15

1.64

 Chlorpromazine equivalent

1.00

1.00

1.00

1.00

 ANT-attitude

1.05**

1.05**

1.04*

1.04*

 ANT-insight

1.00

1.00

0.99

1.00

 ANT-adverse effects

1.02

1.02

1.01

1.01

 BPRS_total

0.98

 BPRS_positive symptoms

0.98

 HONOS_total

1.03

 HONOS_behaviour

1.45

 HONOS_impairment

1.06

 HONOS_symptoms

0.79

 HONOS_social

1.34

 ADL

0.76

0.73

0.79

0.74

 IADL

1.07

1.16

1.11

1.11

 social functioning

0.85

0.85

0.79

0.84

 Nagelkerke R square

0.29

0.30

0.26

0.33

 p for the model

< 0.01

< 0.001

< 0.01

< 0.01

Age

0.99

1.00

0.99

0.93

Sex

3.82

4.23

4.23

19.31

Chlorpromazine equivalent

1.00

1.00

1.00

1.00

ANT-attitude

1.04

1.04

1.05

1.02

ANT-insight

1.00

1.00

0.98

1.00

ANT-adverse effects

1.02

1.03

1.02

1.07

BPRS_total

0.99

BPRS_positive symptoms

0.96

HONOS_total

0.93

HONOS_behaviour

14.71

HONOS_impairment

0.39

HONOS_symptoms

0.78

HONOS_social

1.11

ADL

2.50

2.66

1.92

2.82

IADL

1.58

1.50

1.55

2.37*

social functioning

0.78

0.84

0.79

0.71

Nagelkerke R square

0.24

0.25

0.30

0.38

p for the model

0.31

0.28

0.21

0.15